You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CALCIUM GLUCONATE IN SODIUM CHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Calcium Gluconate In Sodium Chloride, and when can generic versions of Calcium Gluconate In Sodium Chloride launch?

Calcium Gluconate In Sodium Chloride is a drug marketed by Amneal, Fresenius Kabi Usa, and Hq Spclt Pharma. and is included in three NDAs. There are two patents protecting this drug.

The generic ingredient in CALCIUM GLUCONATE IN SODIUM CHLORIDE is calcium gluconate. There are two hundred and eighty-two drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the calcium gluconate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Calcium Gluconate In Sodium Chloride

A generic version of CALCIUM GLUCONATE IN SODIUM CHLORIDE was approved as calcium gluconate by FRESENIUS KABI USA on June 15th, 2017.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CALCIUM GLUCONATE IN SODIUM CHLORIDE?
  • What are the global sales for CALCIUM GLUCONATE IN SODIUM CHLORIDE?
  • What is Average Wholesale Price for CALCIUM GLUCONATE IN SODIUM CHLORIDE?
Summary for CALCIUM GLUCONATE IN SODIUM CHLORIDE
Drug patent expirations by year for CALCIUM GLUCONATE IN SODIUM CHLORIDE
Recent Clinical Trials for CALCIUM GLUCONATE IN SODIUM CHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ascension Genesys HospitalPhase 2
Aurora Health CarePhase 4
First Affiliated Hospital Xi'an Jiaotong UniversityN/A

See all CALCIUM GLUCONATE IN SODIUM CHLORIDE clinical trials

Pharmacology for CALCIUM GLUCONATE IN SODIUM CHLORIDE

US Patents and Regulatory Information for CALCIUM GLUCONATE IN SODIUM CHLORIDE

CALCIUM GLUCONATE IN SODIUM CHLORIDE is protected by two US patents and one FDA Regulatory Exclusivity.

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 217174-001 Sep 5, 2023 AP RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Hq Spclt Pharma CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 210906-003 Jun 4, 2021 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Fresenius Kabi Usa CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 208418-005 Jun 17, 2021 AP RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

CALCIUM GLUCONATE IN SODIUM CHLORIDE Market Analysis and Financial Projection Experimental

Calcium Gluconate in Sodium Chloride: Market Dynamics and Financial Trajectory

Introduction

Calcium gluconate in sodium chloride is a critical medical formulation used to treat various calcium deficiency-related conditions. This article delves into the market dynamics, financial trajectory, and key factors influencing the growth of this market.

Market Size and Growth Projections

The global calcium gluconate market is poised for significant growth. By 2025, the market size is estimated to reach $976 million, growing at a CAGR of 6.29% during the forecast period of 2020-2025[1].

For the longer term, the global calcium gluconate market is projected to expand substantially. By 2033, the market is anticipated to surpass $179.31 billion, growing at a CAGR of 6.15% from 2024 to 2033[4].

Regional Market Analysis

Asia Pacific

The Asia Pacific region holds a significant share of the calcium gluconate market, with approximately 43% of the overall market share. Countries like China and India are major consumption regions due to advanced production technologies and a wide range of downstream applications. Government spending on infrastructure development and increasing health consciousness are key drivers of market growth in this region[1].

North America

North America dominates the global calcium gluconate market, driven by the widespread use of calcium gluconate in pharmaceuticals to treat calcium deficiency, osteoporosis, and other bone-related conditions. The U.S. market, in particular, is expected to grow rapidly, with the market size projected to reach around $51.78 billion by 2033 at a CAGR of 6.28% from 2024 to 2033[4].

Europe

The European market for calcium gluconate was valued at $26.65 billion in 2023 and is expected to expand to around $49.31 billion by 2033, growing at a CAGR of 6.28% during the forecast period. Increasing health awareness and the demand for calcium supplements are key factors driving this growth[4].

Application Segments

Pharmaceuticals

The pharmaceutical sector is a major consumer of calcium gluconate, particularly for treating conditions such as hypocalcemia, cardiac arrest, and hypermagnesemia. In 2019, pharmaceuticals generated the highest revenue in the calcium gluconate market and are expected to continue growing during the forecast period[1].

Food & Beverages

The food and beverage industry is another significant segment, with a projected CAGR of 5.87% during the forecast period. The increasing use of calcium gluconate as a nutritional additive in various food products drives this growth[1].

Nutraceuticals and Personal Care

Calcium gluconate is also widely used in the nutraceutical and personal care industries. Its role in promoting bone health and skincare makes it a sought-after ingredient in health supplements and cosmetic products[4].

End-Use Segments

Bulking Agent, Emulsifier, and Thickening Agent

The bulking agent segment dominated the market in terms of revenue in 2019 and is expected to continue growing. The high demand in the pharmaceutical and food industries for these functions drives this segment's growth[1].

Form and Function

Liquid, Powder, and Tablet Forms

The powder form of calcium gluconate is currently dominant, but the liquid form is the fastest-growing segment due to its ease of use and quick absorption, especially in emergency medical situations[4].

Calcium Supplement

The calcium supplement segment holds the largest share of the market and is expected to grow at the fastest rate. Calcium gluconate is widely used to combat calcium deficiencies and promote bone health, making it a preferred choice for daily supplementation[4].

Drivers of Market Growth

Increasing Demand

The rising demand from industries such as pharmaceuticals, food & beverages, and nutraceuticals is a key driver of the calcium gluconate market. The benefits of calcium gluconate in treating calcium deficiencies and other health conditions contribute to its increasing demand[1].

Health Awareness and Consumer Preferences

Growing health awareness and evolving consumer preferences, particularly in regions like Asia Pacific, drive the demand for calcium gluconate. The increasing intake of calcium gluconate in different food products and health supplements is a significant factor[4].

Challenges and Restraints

Excessive Intake

One of the challenges facing the calcium gluconate market is the risk associated with excessive intake. High levels of calcium can lead to adverse health effects, which can restrain market growth[1].

Side Effects

Side effects associated with calcium gluconate, such as gastrointestinal issues, can also act as a restraint. However, these are generally manageable with proper dosage and administration[4].

Financial Performance

U.S. Market

In the U.S., the annual sales for calcium gluconate in sodium chloride injection were $107 million for the 12 months ended June 2023. This indicates a strong financial performance and potential for continued growth[3].

Global Market

The global market's financial trajectory is robust, with the market size expected to more than double from $98.72 billion in 2023 to $179.31 billion by 2033. This growth is driven by increasing demand and expanding applications across various industries[4].

Key Players and Competitive Landscape

The global calcium gluconate market is highly competitive and consolidated, with both regional and international players. Innovation and product development are key strategies adopted by leading players to maintain market share. Companies like Amneal, which recently received FDA approval for their calcium gluconate injection, are examples of players driving market growth through innovation[1][3].

Conclusion

The market for calcium gluconate in sodium chloride is poised for significant growth driven by increasing demand from pharmaceutical, food & beverage, and nutraceutical industries. The Asia Pacific and North American regions are expected to be major drivers of this growth. Despite challenges such as excessive intake and side effects, the market's financial trajectory remains strong, with a projected global market size of over $179 billion by 2033.

Key Takeaways

  • The global calcium gluconate market is expected to reach $179.31 billion by 2033.
  • Asia Pacific and North America are key regions driving market growth.
  • The pharmaceutical sector is a major consumer of calcium gluconate.
  • The liquid form of calcium gluconate is the fastest-growing segment.
  • Increasing health awareness and consumer demand are driving market growth.
  • Excessive intake and side effects are potential restraints.

FAQs

What are the primary applications of calcium gluconate in sodium chloride?

Calcium gluconate in sodium chloride is primarily used in the treatment of acute symptomatic hypocalcemia, cardiac arrest, and conditions related to hyperkalemia or hypermagnesemia[2].

Which region dominates the global calcium gluconate market?

North America currently dominates the global calcium gluconate market, driven by its widespread use in pharmaceuticals and other health-related applications[4].

What is the projected CAGR for the global calcium gluconate market from 2024 to 2033?

The global calcium gluconate market is expected to grow at a CAGR of 6.15% from 2024 to 2033[4].

What are the main forms of calcium gluconate available in the market?

Calcium gluconate is available in liquid, powder, and tablet forms, with the powder form currently dominant but the liquid form growing rapidly[4].

What are the potential side effects of excessive calcium gluconate intake?

Excessive intake of calcium gluconate can lead to adverse health effects such as gastrointestinal issues and other complications[1].

Sources

  1. IndustryARC, "Calcium Gluconate Market - Forecast(2024 - 2030)".
  2. FDA, "Calcium Gluconate in Sodium Chloride Injection".
  3. Amneal, "Amneal Receives U.S. FDA Approval for Calcium Gluconate Injection".
  4. Precedence Research, "Calcium Gluconate Market Size to Surpass USD 179.31 Bn by 2033".
  5. NCBI Bookshelf, "Calcium Gluconate - StatPearls".

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.